2 completed, 1 recruiting. 1 Phase 1, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Recruiting 1 |
| Phase 4 | 1 | Completed 1 |
Follow Normal Saline as Placebo: new trials by email Literature Review of Normal Saline as Placebo trials Research Report on Normal Saline as Placebo
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 3 Study of NTLA-2001 in ATTRv-PN nexiguran ziclumeran, Normal Saline as Placebo - Neuromuscular Disease, Neuromuscular Diseases (NMD) | Phase 3 | Recruiting | Intellia Therapeutics | 60 | 2024-11-22 | 2026-04-16 |
| Effect of Intraoperative Dexmedetomidine on Early Postoperative Cognitive Dysfunction Dexmedetomidine Injection - Cognitive Dysfunction | Phase 4 | Completed | Tata Main Hospital | 120 | 2017-10-01 | 2024-09-19 |
| Pilot Study of Bumetanide for Newborn Seizures Bumetanide, Normal Saline as Placebo - Seizures | Phase 1 | Completed | Soul, Janet , M.D. | 43 | 2010-01-01 | 2020-12-17 |
Amyloid Neuropathies (1) · Amyloid Neuropathies, Familial (1) · Amyloidosis (1) · Amyloidosis, Familial (1) · Amyloidosis, Hereditary, Transthyretin-Related (1) · Cognitive Dysfunction (1) · Genetic Diseases, Inborn (1) · Heredodegenerative Disorders, Nervous System (1) · Hypoxia-Ischemia, Brain (1) · Intracranial Hemorrhages (1) · Metabolic Diseases (1) · Metabolism, Inborn Errors (1) · Nervous System Diseases (1) · Neurodegenerative Diseases (1) · Neuromuscular Diseases (1)
Intellia Therapeutics (1) · Soul, Janet , M.D. (1) · Tata Main Hospital (1)
Argentina (1) · Brazil (1) · India (1) · Mexico (1) · Singapore (1) · Taiwan (1) · Thailand (1) · United States (1)
Dr.Deb S Nag, MD (1) · Janet Soul, MD,CM (1)
R01NS066929 (1)